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Abstract Given the potent hydrolyzing activity toward phos-
phatidylcholine, group X secretory phospholipase A2 (sPLA2-X)
elicits a marked release of arachidonic acid linked to the potent
production of lipid mediators in various cell types. We have
recently shown that sPLA2-X can also act as a ligand for mouse
phospholipase A2 receptor (PLA2R). Here, we found that
sPLA2-X was internalized and degraded via binding to PLA2R
associated with the diminished prostaglandin E2 (PGE2) forma-
tion in PLA2R-expressing Chinese hamster ovary (CHO) cells
compared to CHO cells. Indirect immunocytochemical analysis
revealed that internalized sPLA2-X was co-localized with
PLA2R in the punctate structures in PLA2R-expressing CHO
cells. Moreover, in mouse osteoblastic MC3T3-E1 cells that
endogenously express the PLA2R, the internalized sPLA2-X was
localized in lysosomes. These findings demonstrate that PLA2R
acts as a clearance receptor for sPLA2-X to suppress its strong
enzymatic activity. ß 2001 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Secretory phospholipase A2s (sPLA2s) are a growing family
of enzymes that hydrolyze the sn-2 fatty acid ester bonds of
glycerophospholipids to produce free fatty acids and lyso-
phospholipids [1,2]. sPLA2s have several common character-
istics including a relatively low molecular mass (13^18 kDa),
the presence of 6^8 disul¢de bridges, and an absolute catalytic
requirement for millimolar concentrations of Ca2 [3,4]. At
present, mammalian sPLA2s are classi¢ed into 10 di¡erent
groups depending on the primary structure characterized by
the number and positions of cysteine residues (IB, IIA, IIC,
IID, IIE, IIF, III, V, X and XII) [5^7]. Among them, group X
sPLA2 (sPLA2-X) has 16 cysteine residues located at positions
characteristic of the classical types of group IB and IIA
sPLA2s (sPLA2-IB and sPLA2-IIA), and also has an amino
acid C-terminal extension that is typical of group II sPLA2
subtypes [8]. We have recently shown that sPLA2-X is one of
the enzymes that possesses a potent hydrolyzing activity to-
ward phosphatidylcholine, a major component of the extra-
cellular face of the plasma membrane of mammalian cells [9].
In fact, sPLA2-X can induce potent release of arachidonic
acid leading to cyclooxygenase (COX)-dependent prostaglan-
din (PG) formation, as well as marked production of lyso-
phosphatidylcholine in various cell types, including macro-
phages, spleen cells and colon cancer cells [10^12]. Given its
high expression in macrophages and invasive colon cancers,
sPLA2-X is thought to play a crucial role in the progression of
various disease states, including in£ammation and colon tu-
morigenesis, via the production of lipid mediators.
In addition to its digestive function, sPLA2-X has recently
been identi¢ed as a high-a⁄nity ligand for the phospholipase
A2 receptor (PLA2R) in mice [11,13]. PLA2R is a type I trans-
membrane glycoprotein composed of a large extracellular
portion including a characteristic tandem repeat of eight carbo-
hydrate-recognition domains. Its overall molecular organiza-
tion is related to unique members (subgroup VI) of the C-type
animal lectin family, such as the macrophage mannose receptor
and DEC-205 [14,15]. In the ligand^receptor relationship, there
is strict species speci¢city, and sPLA2-IB has been identi¢ed as a
high-a⁄nity ligand of PLA2R in mice [16]. sPLA2-IIA is a rel-
atively weaker ligand and group IID sPLA2 cannot bind to
PLA2R [16,17]. For the high-a⁄nity receptor binding, proteo-
lytic removal of the propeptide of sPLA2-X is required, being
similar to the case of sPLA2-IB [13]. PLA2R is abundantly ex-
pressed in type II alveolar epithelial cells in accordance with the
expression of sPLA2-IB and sPLA2-X [18]. We have recently
shown that PLA2R plays a critical role in the production of
pro-in£ammatory cytokines during the progression of endo-
toxic shock by study of PLA2R-de¢cient mice [19,20]. As for
sPLA2-IB, we have found that it elicits various biological re-
sponses via binding to PLA2R, including lipid mediator produc-
tion and cell proliferation [21]. In addition, PLA2R is involved
in the internalization and degradation of sPLA2-IB [22] and
exogenous ligands, such as snake venom sPLA2 [23].
The powerful enzymatic activity of sPLA2-X suggests that
knowing about its PLA2R-mediated responses would be in-
dispensable for understanding its physiological and patholog-
ical functions. In the present study, we found that sPLA2-X
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was rapidly internalized and degraded after PLA2R binding,
thus resulting in a decrease in PGE2 production. Further anal-
ysis with indirect immuno£uorescent and immunoelectron mi-
croscopy revealed the transport of sPLA2-X into lysosomes
after PLA2R binding, which indicates that PLA2R has a crit-
ical role as the clearance receptor for sPLA2-X.
2. Materials and methods
2.1. Materials
Sodium [125I]iodine (carrier-free, 3.7 GBq/ml) was purchased from
Amersham Pharmacia Biotech. Puri¢ed recombinant mouse sPLA2-X,
rabbit anti-sPLA2-X antibody (Ab), and rat monoclonal anti-PLA2R
Ab (912F) were prepared as described in our previous paper [18]. The
speci¢city of rabbit anti-sPLA2-X Ab was con¢rmed by its neutraliz-
ing e¡ect on sPLA2-X enzymatic activity with no inhibitory potency
against other sPLA2 enzymes [9]. The speci¢city of 912F for PLA2R
was also con¢rmed by a sandwich enzyme-linked immunosorbent as-
say (ELISA) system, in which the signal for circulating the soluble
form of the receptor was absent in plasma prepared from PLA2R-
de¢cient mice [18].
2.2. Comparison of sPLA2-X-induced PGE2 production and the
stability of sPLA2-X between PLA2R-CHO and CHO cells
Chinese hamster ovary (CHO) cells stably expressing mouse PLA2R
(PLA2R-CHO cells) were prepared as described previously [11]. Hu-
man COX-2 cDNA and its expression plasmid were prepared [24] and
transiently expressed in CHO and PLA2R-CHO cells with Lipofect-
Amine PLUS reagent (Life Technologies) according to the instruc-
tions of the manufacturer. Cells were grown in 96-well microplates
in K-minimum essential medium (MEM), 10% fetal calf serum (FCS).
After washing with phosphate-bu¡ered saline (PBS), the cells were
incubated with 25 nM mouse sPLA2-X in K-MEM, 0.1% bovine se-
rum albumin (BSA) at 37‡C for various times. After incubation, the
supernatant was collected following centrifugation at 1000Ug for 5
min at 4‡C. The released PGE2 was quanti¢ed with PGE2 EIA Mono-
clonal Kit (Cayman Chemicals Co.). In separate experiments, PLA2R-
CHO and CHO cells were incubated with mouse sPLA2-X for various
times at 37‡C. The residual PLA2 activity in the supernatant was
determined by chromogenic assay, as described previously [11].
Brie£y, the supernatant was incubated with mixed micelles consisting
of 1 mM 1,2-bis(heptanoylthio)-1,2-dideoxy-rac-glycero-3-phospho-
choline and 0.3 mM Triton X-100 in the assay bu¡er containing 25
mM Tris^HCl bu¡er (pH 7.5), 0.12 mM 5,5P-dithiobis(2-nitrobenzoic
acid), 10 mM CaCl2, 0.1 M KCl, and 1 mg/ml BSA. The reaction was
monitored at the absorbance of 405 nm with a microplate reader, and
the amount of the active form of sPLA2-X in the supernatant was
calculated from a standard curve using intact sPLA2-X.
2.3. Kinetic studies on ligand internalization
Iodination of mouse sPLA2-X was performed by the chloramine T
method, as described previously [22], and the speci¢c radioactivity of
125I-sPLA2-X was 1200 cpm/fmol. PLA2R-CHO cells were grown in
24-well plates in K-MEM, 10% FCS. After washing with PBS, the cells
were incubated with 1 nM 125I-labeled mouse sPLA2-X in binding
medium (Hank’s balanced salt solution containing 0.1% BSA) for
2 h at 4‡C. The cells were washed with PBS, resuspended in binding
medium, and then incubated at 37‡C. At the end of the incubation,
the supernatant was removed and the cells were treated with an acidic
bu¡er (50 mM glycine, 0.1 M NaCl, pH 3.0) for 10 min at 4‡C. The
acidic bu¡er was harvested, and its radioactivity was determined. The
residual cell-associated radioactivity was determined after solubiliza-
tion of the cells with 1 N NaOH. The supernatant was precipitated
with 10% trichloroacetic acid, and the trichloroacetic acid-soluble and
-insoluble radioactivity was determined. The speci¢c binding was cal-
culated by subtracting the non-speci¢c binding obtained with 100 nM
mouse sPLA2-X.
2.4. Analysis by indirect immuno£uorescence microscopy
After incubation with mouse sPLA2-X at 37‡C, the cells were
washed with PBS and ¢xed with 4% paraformaldehyde in Na-phos-
phate bu¡er (pH 7.2) for 4 h at room temperature. After washing with
PBS, the cells were permeabilized with 0.1% Triton X-100 in PBS for
15 min. They were incubated with 1% skim milk in PBS for 15 min to
block non-speci¢c binding followed by incubation with primary Abs,
including rabbit anti-sPLA2-X Ab (6 Wg/ml), rat anti-PLA2R Ab
(912F, 15 Wg/ml), or rat monoclonal Ab for lysosome-associated mem-
brane protein type 2 (LAMP-2) (ABL-93 obtained from BD Pharmin-
gen, 2.5 Wg/ml). After rinsing with PBS, the cells were incubated with
£uorescent-labeled secondary Abs, such as Alexa Fluor 488-labeled
goat anti-rabbit immunoglobulin G (IgG) Ab and/or Alexa Fluor 594-
labeled goat anti-rat IgG Ab (Molecular Probes, 10 Wg/ml). After
washing with PBS, the coverslips were mounted with Aqua Poly/
Mount (Polysciences) and viewed under a laser confocal microscope
(TCS NT; Leica). Green and red indicate the localization of signals of
Alexa Fluor 488 and 594, respectively.
2.5. Analysis by immunoelectron microscopy
After incubation with 50 nM sPLA2-X for 24 h, mouse osteoblastic
MC3T3-E1 cells (ATCC) were washed and ¢xed in 4% paraformalde-
hyde in Na-phosphate bu¡er (pH 7.2) as described above. The cells
were dehydrated in a graded series of ethanol and embedded in LR-
White (London Resin). Ultrathin sections (70 nm) were mounted on
collodion-treated nickel grids. The sections were allowed to react with
anti-sPLA2-X Ab followed by incubation with colloidal gold (5 nm)-
conjugated goat anti-rabbit IgG Ab (E-Y Laboratories). After wash-
ing, the sections were counterstained with uranyl acetate and observed
under a transmission electron microscope (JEOL, JEM-1200EX).
3. Results and discussion
3.1. Comparison of sPLA2-X-induced PGE2 production and the
stability of sPLA2-X between PLA2R-CHO and CHO
cells
In order to examine the involvement of PLA2R in sPLA2-
X-induced responses, we ¢rst compared the potency of
sPLA2-X for PGE2 production between PLA2R-CHO cells
and CHO cells. Since arachidonic acid released by sPLA2-X
can be e⁄ciently converted to PGE2 via COX-2 in various cell
types [10,12], human COX-2 cDNA was transiently intro-
duced into PLA2R-CHO and CHO cells. Western blot anal-
ysis revealed that the expression level of COX-2 protein was
the same between the two cell types (result not shown). In
COX-2-expressing CHO cells, PGE2 production elicited by
exogenous arachidonic acid was markedly elevated compared
to non-transfected cells and its level was comparable in the
case with COX-2-expressing PLA2R-CHO cells (data not
shown). As shown in Fig. 1A, sPLA2-X induced potent
PGE2 production in CHO cells for up to 5 h. In PLA2R-
CHO cells, however, PGE2 production was slightly reduced
at 1 h and markedly decreased after 2 h incubation compared
to CHO cells, suggesting a negative role of PLA2R on sPLA2-
X functions. We then examined the residual enzymatic activity
in the culture medium after incubation of the cells with
sPLA2-X. As shown in Fig. 1B, active sPLA2-X mostly re-
mained in the supernatant during the incubation for up to 24 h
in CHO cells, whereas it gradually diminished from 1 h and
disappeared after 24 h incubation in PLA2R-CHO cells. These
¢ndings suggest that PLA2R plays a role in the clearance of
sPLA2-X resulting in the reduction of its enzymatic potency
for the cell membranes.
3.2. Internalization and degradation of sPLA2-X via PLA2R
Next, we examined the internalization and degradation of
125I-sPLA2-X after binding to PLA2R-CHO cells. After incu-
bation with 125I-sPLA2-X for 2 h at 4‡C, PLA2R-CHO cells
were washed, re-suspended in binding medium and incubated
at 37‡C for various times. After removing the supernatant, the
cells were treated with acidic bu¡er at 4‡C to dissociate the
cell-surface ligand, and the residual cell-associated (acid-resis-
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tant) radioactivity was determined as the intracellular ligand.
As shown in Fig. 2A, most of the cell-bound ligand was re-
moved by the acid wash before the incubation at 37‡C. The
amount of cell-surface ligand gradually decreased upon warm-
ing, while the intracellular radioactivity rises concomitantly,
reaching a plateau after 45 min. The fate of internalized 125I-
sPLA2-X was also examined as follows. The incubation me-
dium after warming was subjected to trichloroacetic acid pre-
cipitation to determine the amount of native (trichloroacetic
acid-insoluble) and degraded (trichloroacetic acid-soluble) li-
gand. As shown in Fig. 2B, about 43% of the pre-bound li-
gand was dissociated from the cell surface as an intact form
during the ¢rst 30 min of warming, which probably was due
to the reversible ligand binding to the receptor. After 45 min
of warming, the degraded ligands began to appear in the
medium and then gradually increased. These ¢ndings demon-
strate that PLA2R can internalize sPLA2-X and promote its
degradation.
3.3. Co-localization of internalized sPLA2-X with PLA2R
In order to determine the subcellular localization of inter-
nalized sPLA2-X and PLA2R, we performed confocal immu-
Fig. 1. Comparison of sPLA2-X-induced PGE2 production and the
stability of sPLA2-X between PLA2R-CHO and CHO cells. A:
After transient transfection with human COX-2 cDNA, PLA2R-
CHO and CHO cells were incubated with 10 nM sPLA2-X for vari-
ous times at 37‡C, and the PGE2 amount in the supernatant was
quanti¢ed. The results were expressed after subtracting the values
obtained from the incubation in the absence of sPLA2-X at each
time point. B: After incubation with sPLA2-X for the indicated
times, the residual PLA2 activity in the supernatant was measured
by chromogenic assay and the amount of the active form of sPLA2-
X was calculated by a standard curve using intact sPLA2-X. The re-
sults are expressed as a percentage of the amount of sPLA2-X origi-
nally added. Each point represents the mean þ S.E.M. of triplicate
measurements. The data are representative of three experiments.
Fig. 2. Internalization and degradation of sPLA2-X in PLA2R-CHO
cells. After incubation with 2 nM 125I-sPLA2-X for 2 h at 4‡C,
PLA2R-CHO cells were washed, re-suspended in binding medium
and incubated at 37‡C for the indicated times. After incubation, the
supernatant was removed and the cells were treated with acidic bu¡-
er for 10 min at 4‡C. A: The acidic bu¡er was harvested, and its
radioactivity was determined (a). The residual cell-associated radio-
activity (b) was determined after solubilization of the cells with 1 N
NaOH. B: The supernatant was precipitated with 10% trichloroace-
tic acid, and the trichloroacetic acid-soluble (F) and insoluble (E)
radioactivities were determined. The speci¢c binding was calculated
by subtracting the non-speci¢c binding obtained with 100 nM
mouse sPLA2-X from each point. Each point represents the
mean þ S.E.M. of triplicate measurements. The data are representa-
tive of three experiments.
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no£uorescent microscopic analysis. After incubation with
sPLA2-X for 4 h at 37‡C, PLA2R-CHO cells were ¢xed and
stained with anti-sPLA2-X Ab and anti-PLA2R Ab. Before
the incubation, PLA2R was mostly detected in the plasma
membranes with a small portion at the intracellular punctate
structures (Fig. 3A). After the incubation, sPLA2-X was in-
ternalized (Fig. 3B) and PLA2R was translocated from the cell
surface to the intracellular punctate structures (Fig. 3C). The
overlay of each signal revealed their co-localization in the
dense perinuclear structures and the punctate cytoplasmic
structures that represent the endosome, lysosomes or recycle
compartment (Fig. 3D). In contrast, there were no detectable
signals with both Abs under any conditions in control CHO
cells (results not shown).
3.4. Clearance of sPLA2-X in MC3T3-E1 cells
In order to verify the clearance function of native PLA2R,
we examined the stability of sPLA2-X in mouse osteoblastic
MC3T3-E1 cells that endogenously express high levels of
PLA2R [25]. In this experiment, we used polyclonal anti-
PLA2R Ab that can block the association of sPLA2-X with
mouse PLA2R [18]. As shown in Fig. 4, sPLA2-X activity in
the culture medium gradually decreased during the incubation
with MC3T3-E1 cells, with the activity diminishing to 50%
after 24 h-incubation. Pretreatment with anti-PLA2R Ab re-
sulted in almost complete protection for the decline of enzy-
matic potency in the medium, suggesting that native PLA2R
also acts as a clearance receptor for sPLA2-X.
To determine the compartmentalization of internalized
sPLA2-X via native PLA2R, MC3T3-E1 cells were incubated
with sPLA2-X at 37‡C for 24 h, and then stained with anti-
sPLA2-X Ab (Fig. 5A) or Ab against LAMP-2 (Fig. 5B), a
known lysosomal marker. The overlay of each signal obtained
Fig. 3. Confocal microscopic analysis of subcellular localization of
internalized PLA2R and sPLA2-X. PLA2R-CHO cells were incu-
bated without (A) or with (B^D) 50 nM sPLA2-X for 4 h at 37‡C.
The cells were subjected to indirect immuno£uorescent microscopy
as described in Section 2. The red and green areas indicate the
staining signals for sPLA2-X (B) and PLA2R (C), respectively, and
the yellow areas indicate the regions where PLA2R and sPLA2-X
are co-localized (D). Each photograph has the same magni¢cation.
The bar indicates 10 Wm.
Fig. 4. Clearance of sPLA2-X in MC3T3-E1 cells. MC3T3-E1 cells
were pre-incubated with anti-PLA2R Ab or control rabbit IgG for
1 h at 37‡C, and then treated with 10 nM sPLA2-X for the indi-
cated times at 37‡C. The residual PLA2 activity in the supernatant
was measured and the amount of sPLA2-X was calculated. The re-
sults are expressed as the percentage of the amount of sPLA2-X
originally added. Each point represents the mean þ S.E.M. of tripli-
cate measurements. The data are representative of three experi-
ments.
Fig. 5. Localization of internalized sPLA2-X in lysosomes. A^C:
MC3T3-E1 cells were incubated with 50 nM sPLA2-X for 24 h and
then subjected to indirect immuno£uorescent microscopy as de-
scribed in Section 2. The red and green areas indicate the staining
signals of sPLA2-X (A) and LAMP-2 (B), respectively. The overlay
(C) shows co-localization of sPLA2-X and LAMP-2, and yellow
areas indicate the regions where sPLA2-X is co-localized with
LAMP-2. Each bar indicates 10 Wm. D: MC3T3-E1 cells were incu-
bated with 50 nM sPLA2-X for 24 h. After ¢xation of the cells, ul-
trathin sections of the cells were reacted with anti-sPLA2-X Ab fol-
lowed by incubation with colloidal gold (5 nm)-conjugated goat
anti-rabbit IgG Ab. After washing, the sections were counterstained
with uranyl acetate. The bar indicates 200 nm.
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with confocal microscopy clearly demonstrates that the inter-
nalized ligand is transported into the lysosomes (Fig. 5C).
Furthermore, analysis by immunoelectron microscopy also
revealed that the colloidal gold representative of internalized
sPLA2-X was localized at the lysosome-like structures (Fig.
5D). In contrast, there were no detectable signals of anti-
sPLA2-X Ab in MC3T3-E1 cells without incubation of
sPLA2-X (results not shown).
Endocytosis is one of the innate host defense systems against
microorganisms and toxic molecules [26]. It has been noted
that sPLA2-X possesses a potent hydrolyzing activity toward
intact cell membranes leading to marked production of various
types of lipid mediators [9]. In the present study, PGE2 pro-
duction by sPLA2-X was diminished by clearance of the active
form of sPLA2-X in PLA2R-CHO cells (Fig. 1). Since sPLA2-
X is expressed in the lung and spleen where PLA2R is co-
localized in type II alveolar epithelial cells and is present in
the neighboring splenic lymphocytes [18], PLA2R might act as
part of the endogenous defense system by withdrawing sPLA2-
X from the extracellular £uid. This could be of crucial impor-
tance in various disease states when high levels of sPLA2-X are
detected, such as invasive colon cancers [12]. Although
PLA2R-mediated endocytosis has been observed with other
sPLA2 ligands, including sPLA2-IB and snake venom sPLA2
[11,13], the compartmentalization of these ligands and receptor
following internalization has not been studied because of the
unavailability of their speci¢c Abs. In the present study, we
identi¢ed the localization of internalized sPLA2-X and PLA2R
in the vesicular structures representative for endosome, lyso-
somes or recycling compartment in CHO cells by confocal
immuno£uorescent microscopy. In the absence of sPLA2-X,
PLA2R was also located at the intracellular punctate struc-
tures (Fig. 3A), suggesting a ligand-independent intracellular
tra⁄cking of the receptor as proposed for rabbit PLA2R [23].
In fact, the internalization rate constant of PLA2R for sPLA2-
X (ke = 0.023 min31), calculated from kinetic studies (Fig. 3),
is comparable with the rates of other constitutively recycling
receptors, including its structural homolog, the mannose re-
ceptor [23,27]. In MC3T3-E1 cells that express native PLA2R,
the internalized sPLA2-X was transported into the lysosomes
where the ligand could be degraded (Fig. 4).
In conclusion, we have demonstrated that PLA2R plays a
critical role in the clearance of sPLA2-X. With respect to
sPLA2-IB, PLA2R can mediate various biological responses
after recognition of this ligand, including cell proliferation
and lipid mediator production [21]. Recent studies have also
shown that sPLA2-IB is targeted to the nucleus after its bind-
ing to the cell surface [28]. These ¢ndings suggest that sPLA2-
X binding to PLA2R might be linked to some signal trans-
duction systems leading to the induction of biological re-
sponses. Alternatively, the endosomal vesicles may serve as
a vehicle delivering sPLA2-X to speci¢c intracellular compart-
ments where the enzyme can work before being degraded in
the lysosomes. Further studies on the PLA2R-mediated endo-
cytosis and signaling events of sPLA2-X in various tissues and
species should lead to further understanding of the physiolog-
ical and pathological functions of sPLA2-X.
References
[1] Vadas, P. and Pruzanski, W. (1986) Lab. Invest. 55, 391^404.
[2] Arita, H., Nakano, T. and Hanasaki, K. (1989) Prog. Lipid Res.
28, 273^301.
[3] Tisch¢eld, J.A. (1997) J. Biol. Chem. 272, 17247^17250.
[4] Lambeau, G. and Lazdunski, M. (1999) Trends Pharmacol. Sci.
20, 162^170.
[5] Six, D.A. and Dennis, E.A. (2000) Biochim. Biophys. Acta 1488,
1^19.
[6] Valentin, E., Ghomashchi, F., Gelb, M.H., Lazdunski, M. and
Lambeau, G. (2000) J. Biol. Chem. 275, 7492^7496.
[7] Gelb, M.H., Valentin, E., Ghomashchi, F., Lazdunski, M. and
Lambeau, G. (2000) J. Biol. Chem. 275, 39823^39826.
[8] Cupillard, L., Koumanov, K., Mattei, M.G., Lazdunski, M. and
Lambeau, G. (1997) J. Biol. Chem. 272, 15745^15752.
[9] Hanasaki, K., Ono, T., Saiga, A., Morioka, Y., Ikeda, M., Ka-
wamoto, K., Higashino, K., Nakano, K., Yamada, K., Ishizaki,
J. and Arita, H. (1999) J. Biol. Chem. 274, 34203^34211.
[10] Saiga, A., Morioka, Y., Ono, T., Nakano, K., Ishimoto, Y.,
Arita, H. and Hanasaki, K. (2001) Biochim. Biophys. Acta
1530, 67^76.
[11] Morioka, Y., Saiga, A., Yokota, Y., Suzuki, N., Ikeda, M., Ono,
T., Nakano, K., Fujii, N., Ishizaki, J., Arita, H. and Hanasaki,
K. (2000) Arch. Biochem. Biophys. 381, 31^42.
[12] Morioka, Y., Ikeda, M., Saiga, A., Fujii, N., Ishimoto, Y., Arita,
H. and Hanasaki, K. (2000) FEBS Lett. 487, 262^266.
[13] Yokota, Y., Higashino, K., Nakano, K., Arita, H. and Hanasaki,
K. (2000) FEBS Lett. 478, 187^191.
[14] Taylor, M.E., Conary, J.T., Lennartz, M.R., Stahl, P.D. and
Drickamer, K. (1990) J. Biol. Chem. 265, 12156^12162.
[15] Jiang, W., Swiggard, W.J., Heu£er, C., Peng, M., Mirza, A.,
Steinman, R.M. and Nussenzweig, M.C. (1995) Nature 375,
151^155.
[16] Cupillard, L., Mulherkar, R., Gomez, N., Kadam, S., Valentin,
E., Lazdunski, M. and Lambeau, G. (1999) J. Biol. Chem. 274,
7043^7051.
[17] Valentin, E., Koduri, R.S., Scimeca, J.C., Carle, G., Gelb, M.H.,
Lazdunski, M. and Lambeau, G. (1999) J. Biol. Chem. 274,
19152^19160.
[18] Yokota, Y., Ikeda, M., Higashino, K., Nakano, K., Fujii, N.,
Arita, H. and Hanasaki, K. (2000) Arch. Biochem. Biophys. 379,
7^17.
[19] Hanasaki, K., Yokota, Y., Ishizaki, J., Itoh, T. and Arita, H.
(1997) J. Biol. Chem. 272, 32792^32797.
[20] Yokota, Y., Hanasaki, K., Ono, T., Nakazato, H., Kobayashi, T.
and Arita, H. (1999) Biochim. Biophys. Acta 1438, 213^222.
[21] Hanasaki, K. and Arita, H. (1999) Arch. Biochem. Biophys. 372,
215^223.
[22] Hanasaki, K. and Arita, H. (1992) J. Biol. Chem. 267, 6414^
6420.
[23] Zvaritch, E., Lambeau, G. and Lazdunski, M. (1996) J. Biol.
Chem. 271, 250^257.
[24] Hsi, L.C., Baek, S.J. and Eling, T.E. (2000) Exp. Cell Res. 256,
563^570.
[25] Tohkin, M., Kishino, J., Ishizaki, J. and Arita, H. (1993) J. Biol.
Chem. 268, 2865^2871.
[26] Mukherjee, S., Ghosh, R.N. and Max¢eld, F.R. (1997) Physiol.
Rev. 77, 759^803.
[27] Wiley, H.S. and Cunningham, D.D. (1982) J. Biol. Chem. 257,
4222^4229.
[28] Fayard, J.M., Tessier, C., Pageaux, J.F., Lagarde, M. and Lau-
gier, C. (1998) J. Cell Sci. 111 (Part 7), 985^994.
FEBS 25560 5-12-01 Cyaan Magenta Geel Zwart
Y. Yokota et al./FEBS Letters 509 (2001) 250^254254
